Allopathic Medicine Practitioners' perspectives on facilitating disclosure of traditional medicine use in Gauteng, South Africa: a qualitative study.
Practitioner-patient approach
Qualitative study
Traditional medicine disclosure
Treatment choice
Journal
BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232
Informations de publication
Date de publication:
12 Dec 2023
12 Dec 2023
Historique:
received:
20
03
2023
accepted:
21
11
2023
medline:
13
12
2023
pubmed:
13
12
2023
entrez:
13
12
2023
Statut:
epublish
Résumé
Traditional medicine (TM) plays a key role in maintaining health in many societies. Given the requirement for TM disclosure, Allopathic Medicine Practitioners (AMPs) must encourage open communication with patients to persuade those who use TM to disclose. Addressing patient non-disclosure of TM requires this dialogue to be facilitated. We sought to understand and describe how South African AMPs facilitate disclosure of TM use during a consultation with patients who use both TM and allopathic medicine (AM) and how it influences the patients' willingness to disclose TM use. This qualitative exploratory descriptive study on AMPs at Gauteng district public hospitals in South Africa was conducted between 2021 and 2022. Non-probability purposive sampling was employed to select a sample of 14 AMPs. Individual participants were encouraged to share their unique experiences and interpretations of the phenomenon concerning TM use disclosure. The raw transcribed textual data were processed using ATLAS.ti, and inductive content analysis was undertaken following the coding of the content to identify categories. The data revealed four major categories: 'providing a suitable atmosphere for disclosure,' 'encouraging patients to disclose TM usage to AMPs,' 'patient autonomy,' and 'AMP training'. During a consultation with patients who use both TM and AM, participants expressed their experiences and perceptions of TM nondisclosure. They also discussed several methods for encouraging patients to disclose their TM usage, particularly when TM is used concurrently with AM. This study expands on previously reported findings by describing how South African AMPs facilitate the disclosure of TM use during consultation. Many AMPs struggle to initiate TM conversations with their patients which results in non-disclosure. This study revealed that integrating TM into AM training programmes, promoting cross-practice, and creating a safe environment is necessary for the development and application of the most appropriate approaches that would assist in facilitating disclosure.
Sections du résumé
BACKGROUND
BACKGROUND
Traditional medicine (TM) plays a key role in maintaining health in many societies. Given the requirement for TM disclosure, Allopathic Medicine Practitioners (AMPs) must encourage open communication with patients to persuade those who use TM to disclose. Addressing patient non-disclosure of TM requires this dialogue to be facilitated. We sought to understand and describe how South African AMPs facilitate disclosure of TM use during a consultation with patients who use both TM and allopathic medicine (AM) and how it influences the patients' willingness to disclose TM use.
METHODS
METHODS
This qualitative exploratory descriptive study on AMPs at Gauteng district public hospitals in South Africa was conducted between 2021 and 2022. Non-probability purposive sampling was employed to select a sample of 14 AMPs. Individual participants were encouraged to share their unique experiences and interpretations of the phenomenon concerning TM use disclosure. The raw transcribed textual data were processed using ATLAS.ti, and inductive content analysis was undertaken following the coding of the content to identify categories.
RESULTS
RESULTS
The data revealed four major categories: 'providing a suitable atmosphere for disclosure,' 'encouraging patients to disclose TM usage to AMPs,' 'patient autonomy,' and 'AMP training'. During a consultation with patients who use both TM and AM, participants expressed their experiences and perceptions of TM nondisclosure. They also discussed several methods for encouraging patients to disclose their TM usage, particularly when TM is used concurrently with AM.
CONCLUSION
CONCLUSIONS
This study expands on previously reported findings by describing how South African AMPs facilitate the disclosure of TM use during consultation. Many AMPs struggle to initiate TM conversations with their patients which results in non-disclosure. This study revealed that integrating TM into AM training programmes, promoting cross-practice, and creating a safe environment is necessary for the development and application of the most appropriate approaches that would assist in facilitating disclosure.
Identifiants
pubmed: 38087333
doi: 10.1186/s12906-023-04270-8
pii: 10.1186/s12906-023-04270-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
451Subventions
Organisme : DHET University Capacity Development Grant (UCDG)
ID : Application 12 project number 1
Informations de copyright
© 2023. The Author(s).
Références
Fam Med Community Health. 2019 Mar 8;7(2):e000057
pubmed: 32148704
BMC Complement Altern Med. 2019 Sep 18;19(1):259
pubmed: 31533782
PLoS One. 2020 Aug 13;15(8):e0237531
pubmed: 32790714
Complement Ther Med. 2004 Jun-Sep;12(2-3):90-8
pubmed: 15561518
BMJ Glob Health. 2018 Oct 31;3(5):e000895
pubmed: 30483405
S Afr Fam Pract (2004). 2022 Mar 17;64(1):e1-e7
pubmed: 35384681
Complement Med Res. 2018;25(2):76-78
pubmed: 29656295
BMC Complement Altern Med. 2017 Jun 8;17(1):301
pubmed: 28595577
PLoS One. 2017 Apr 17;12(4):e0174731
pubmed: 28414735
Med J Malaysia. 2015 Apr;70(2):86-92
pubmed: 26162383
J Altern Complement Med. 2014 Jan;20(1):12-8
pubmed: 23863085
BMC Complement Altern Med. 2013 Nov 18;13:319
pubmed: 24245611
J Young Pharm. 2011 Jul;3(3):250-5
pubmed: 21897668
Prim Health Care Res Dev. 2018 May;19(3):246-255
pubmed: 29417914
Integr Med Res. 2021 Mar;10(1):100469
pubmed: 32874912
Qual Health Res. 2021 Aug;31(10):1847-1860
pubmed: 33980093
J Integr Med. 2019 Nov;17(6):396-403
pubmed: 31548146
Pharmaceuticals (Basel). 2020 Dec 11;13(12):
pubmed: 33322582
S Afr Med J. 2023 May 05;113(5):19-24
pubmed: 37170605
Sci Rep. 2019 Feb 7;9(1):1573
pubmed: 30733573
Afr J Prim Health Care Fam Med. 2016 Jun 10;8(2):e1-8
pubmed: 27380856
Integr Med Res. 2014 Sep;3(3):126-132
pubmed: 28664088
Complement Ther Med. 2019 Jun;44:151-156
pubmed: 31126548
Pharm Pract (Granada). 2012 Jul;10(3):125-35
pubmed: 24155828
Afr J Prim Health Care Fam Med. 2022 Mar 14;14(1):e1-e13
pubmed: 35384683
Health Policy Plan. 2020 Oct 1;35(8):1070-1083
pubmed: 32516397
Complement Ther Clin Pract. 2020 Aug;40:101225
pubmed: 32798811
JAMA Intern Med. 2016 Apr;176(4):545-6
pubmed: 26999670
J Intercult Ethnopharmacol. 2016 May 04;5(3):312-6
pubmed: 27366358
S Afr Med J. 2016 Jan 12;106(2):159-61
pubmed: 26821894
Front Pharmacol. 2014 Jan 10;4:177
pubmed: 24454289
Evid Based Complement Alternat Med. 2017;2017:5146478
pubmed: 28529529